Evofem Biosciences (EVFM)
(Delayed Data from OTC)
$0.01 USD
0.00 (-3.00%)
Updated Aug 9, 2024 03:55 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Evofem Biosciences, Inc. [EVFM]
Reports for Purchase
Showing records 61 - 80 ( 118 total )
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from our Expert Call with Russ Barrans - Fred Wilkinson
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from our Expert Call with Dr. Lisa Rarick
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Game Plan on Making Amphora into a Blockbuster Contraception
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Surveillance Report Indicates Sexually Transmitted Infections on the Rise; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare- Join Our Doc Call Series on Drug Pricing
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
AMPREVENCE Trial Completed; Top-Line Data in November; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: The More Analysis, The Merrier, Especially When Data-Driven
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
2Q19 Financial Results Reported; All Eyes on Amphora; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
2Q19 - Let''s Dig Deep and Figure Out Amphora''s Commercial Fate
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
With $80M Capital Raise Secured, Potential Launch in 2Q20 Is Within Reach
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
1Q19 Financial Results Reported; Amphora Filing Near Term; Reiterate Buy and Modulating Target to $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare -Recap of 22 Expert Calls in 2018 - 2019 for Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Evofem Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Recap of 22 Expert Calls in 2018 - 2019 for Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y